These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 35893680)
1. Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal. Ramírez Mena A; Ngom NF; Tine J; Ndiaye K; Fortes L; Ndiaye O; Fall M; Gaye A; Ka D; Seydi M; Wandeler G; On Behalf Of The Sen-B Study Group Viruses; 2022 Jul; 14(8):. PubMed ID: 35893680 [TBL] [Abstract][Full Text] [Related]
2. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa. Jaquet A; Wandeler G; Tine J; Dagnra CA; Attia A; Patassi A; Ndiaye A; de Ledinghen V; Ekouevi DK; Seydi M; Dabis F BMC Infect Dis; 2016 Jun; 16():249. PubMed ID: 27267370 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis. Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137 [TBL] [Abstract][Full Text] [Related]
4. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia. Vinikoor MJ; Hamusonde K; Muula G; Asombang M; Riebensahm C; Chitundu H; Sunkuntu-Sichizya V; Bhattacharya D; Sinkala E; Lauer G; Chung R; Mbewe W; Egger M; Bosomprah S; Wandeler G Clin Infect Dis; 2024 Jun; 78(6):1583-1590. PubMed ID: 37997691 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal. Ramírez Mena A; Tine JM; Fortes L; Ndiaye O; Ka D; Ngom NF; Ramette A; Bittel P; Seydi M; Wandeler G; J Viral Hepat; 2022 Jan; 29(1):60-68. PubMed ID: 34610183 [TBL] [Abstract][Full Text] [Related]
6. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study. Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065 [TBL] [Abstract][Full Text] [Related]
7. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574 [TBL] [Abstract][Full Text] [Related]
8. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia. Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G; Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504 [TBL] [Abstract][Full Text] [Related]
9. Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana. Stockdale AJ; Phillips RO; Beloukas A; Appiah LT; Chadwick D; Bhagani S; Bonnett L; Sarfo FS; Dusheiko G; Geretti AM; Clin Infect Dis; 2015 Sep; 61(6):883-91. PubMed ID: 26021992 [TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A; Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia. Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044 [TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study. Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068 [TBL] [Abstract][Full Text] [Related]
13. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573 [TBL] [Abstract][Full Text] [Related]
14. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia. Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G; Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal. Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748 [TBL] [Abstract][Full Text] [Related]
16. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa. Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341 [TBL] [Abstract][Full Text] [Related]
17. Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen. Aurpibul L; Kanjanavanit S; Leerapun A; Puthanakit T J Int Assoc Provid AIDS Care; 2019; 18():2325958218823259. PubMed ID: 30798669 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus infection and its determinants among HIV positive pregnant women: Multicenter unmatched case-control study. Anteneh ZA; Wondaye E; Mengesha EW PLoS One; 2021; 16(4):e0251084. PubMed ID: 33930097 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients. Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study. Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]